January 15, 1999
OTC Journal Newsletter
To OTC Journal Subscribers:
Here is an overview of our January Profile. If what you read interests you, simply click on the link at the bottom of the page, and the full profile will automatically open on your computer screen:
Mirage Holdings (OTC BB: MGHI) is a company that has undergone a major transformation in the last 90 days. On January 8th, 1999, Mirage Holdings announced that it had divested itself of its wholly owned subsidiary, Mirage Collections, and would focus all of its energies on its two technology subsidiaries, Net Solutions Pvt Ltd, and Net Solutions UK. Click Here to read the press release.
Mirage Holdings, Inc (OTC BB: MGHI) currently owns 51% of Net Solutions Pvt Ltd, a Pakistan based corporation and 43% of NetSol UK, a London based corporation. To simplify this profile we will refer to the combined companies as NetSol. Management assures us that by the end of March of this year, Mirage Holdings will own 100% of NetSol and all of it's related and subsidiary companies.
With the divestiture of Mirage Collections, Mirage Holdings' (OTC BB: MGHI) only business interest is NetSol, a software development company with a very compelling and profitable history, and extremely strong growth prospects.
Click here to go to the Mirage Holdings investor relations site.
NetSol's corporate WebSite can be found by clicking on http://www.netsolpk.com. Here you can learn all you need to know about their business.
NetSol is a Pakistan based company which currently employs about 70 software engineers that are highly educated and extremely talented at writing computer code.
Here is NetSol's historical financial performance:
These numbers are very impressive. A Company that opened its doors for business in fiscal 1997, and is now on track to do about $5 million in sales in fiscal 1999, deserves serious investor consideration.
Here's a profitable software development company with the infrastructure to compete for business on the basis of cost that gives them enormous upside potential. Their initial products have been accepted by one of the best companies in the world. Yet the stock still trades in relative obscurity since this Company's transformation has yet to be discovered. Therein lies the opportunity for investors.
For our complete profile on Mirage Holdings, Inc. simply click here. If you have an interest in this Company, and want to be on their mailing list for news releases and updates, please click here, and join their mailing list. You will be automatically notified by E-Mail of any corporate events.
The OTCJournal.com Newsletter is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible. All statements and expressions are the sole opinions of the editors and are subject to change without notice. This profile is neither an offer nor solicitation to buy or sell any securities mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein. The editor, members of the editor's family, and/or entities with which they are affiliated, may own stock in and have other financial dealings with the companies who appear in the publication. OTC Journal Management, the parent company of the OTC Journal Newsletter, has been paid a fee of $50,000 in cash, and 50,000 shares of restricted stock as compensation for representing Mirage Holdings for a period of one year. The OTCJournal.com critiques may contain forward looking statements relating to the expected capabilities of the companies mentioned herein.
THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF OTCJOURNAL.com.
The foregoing information report may include numerous forward-looking statements concerning the company's business and future prospects and other similar statements that do not concern matters of historical fact. The federal securities laws provide a limited ``safe harbor'' for certain forward-looking statements. Forward-looking statements in this information report relating to product development, business prospects and development of a commercial market for technological advances are based on the company's current expectations. The company's current expectations are subject to all of the uncertainties and risks customarily associated with new business ventures including, but not limited to, market conditions, successful product development and acceptance, competition and overall economic conditions, as well as the risk of adverse regulatory actions. The company's actual results may differ materially from current expectations. Readers are cautioned not to put undue reliance on forward-looking statements. The company disclaims any intent or obligation to update publicly these forward-looking statements, whether as a result of new information, future events or for any other reason.
We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission ("SEC") at http://www.sec.gov and/or the National Association of Securities Dealers ("NASD") at http://www.nasd.com. Readers can review all public filings by companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its web site.
The OTC Journal Newsletter is an electronic publication committed to providing our readers with useful information on publicly traded companies. The Newsletter contracts with publicly traded companies and receives compensation from them or third parties as payment for publishing information and opinions about the company and the trading market for their securities. Principals of the Newsletter may also purchase or sell securities of the companies in the open market from time to time. The positions, if any, that the Newsletter or its principals presently maintain in the securities of the companies are disclosed here (click here) and should be considered in making an investment decision regarding these companies securities. The Newsletter and its principals reserve the right to acquire additional shares or liquidate some or all of the positions they may hold in the issuer’s securities at any time in the future without further notice. These publications should not be considered to be independent publications concerning the company.
All statements and opinions expressed herein are those of the editors and are subject to change without notice. The Newsletter maintains editorial control over its publications and the companies profiled therein do not have any editorial rights concerning the information published about them. While we believe all sources of information provided by us and contained in our publication to be accurate and reliable, we cannot and do not guarantee the accuracy of information we received from third parties.
We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission ("SEC") at http://www.sec.gov and/or the National Association of Securities Dealers ("NASD") at http://www.finra.org. We also recommend that you read the SEC advisory to investors concerning Internet Stock Fraud, which can be found at http://www.sec.gov/consumer/cyberfr.htm. Readers can review all public filings by companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its web site.
The information found in this profile is protected by the copyright laws of the United States and may not be copied, or reproduced in any way without the express written consent of the editors of otcjournal.com.